| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/15/2006 | EP1140044B1 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION |
| 03/15/2006 | EP1087756A4 Particulate acellular tissue matrix |
| 03/15/2006 | EP1044022B1 Compositions and methods for targeted delivery of factors |
| 03/15/2006 | EP0942973B1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 03/15/2006 | EP0784477B1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 03/15/2006 | CN1747744A Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 03/15/2006 | CN1747741A Treatment of inflammatory bowel disease |
| 03/15/2006 | CN1747737A Carbohydrate conjugates to prevent abuse of controlled substances |
| 03/15/2006 | CN1747736A Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 03/15/2006 | CN1747734A Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders |
| 03/15/2006 | CN1747731A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 03/15/2006 | CN1747728A Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 03/15/2006 | CN1747719A Topical compositions and methods for treating pain |
| 03/15/2006 | CN1745850A Implant agent for treating ophthalmopathy |
| 03/15/2006 | CN1745726A Alimentary stent with biological degradable medicine slow-releasing membrane coating |
| 03/15/2006 | CN1245417C Prodrugs of dipeptidyl peptidase IV inhibitors |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/15/2006 | CN1245161C A method of modulating ion channel functional activity |
| 03/15/2006 | CN1245155C Oral pharmaceutical pulsed release dosage form |
| 03/14/2006 | US7012100 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012096 Comprising a weak organic acid such as acetic acid, vinegar, and/or citric acid dispersed within a carrier, at acidic pH, for treating burns; provides local analgesia |
| 03/14/2006 | US7012087 Anticancer agents |
| 03/14/2006 | US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | US7012068 Reduced toxicity; enhance efficiency; side effect reduction |
| 03/14/2006 | US7012066 for coadministration with interferon and antiviral agent |
| 03/14/2006 | US7012064 Cyclosporins for the treatment of immune disorders |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011854 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 03/14/2006 | US7011839 Combination of an antimicrobial, especially a quinolone antibiotic, and silver sulfadiazine |
| 03/14/2006 | US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route |
| 03/09/2006 | WO2006025583A1 External preparation of s/o type |
| 03/09/2006 | WO2006025431A1 Antagonist against tolerance to anticancer drugs |
| 03/09/2006 | WO2006025395A1 Drug and treating system for chronic obstructive pulmonary disease by using carrier-free cell growth factor |
| 03/09/2006 | WO2006025324A1 Tropan compound |
| 03/09/2006 | WO2006025267A1 Remedy for sleep disorders using lowering in per2 protein level as the action mechanism |
| 03/09/2006 | WO2006024931A2 Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| 03/09/2006 | WO2006024492A2 Medical implant provided with inhibitors of atp synthesis |
| 03/09/2006 | WO2006024491A1 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024490A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024489A2 Methods and compositions for the treatment of cell proliferation |
| 03/09/2006 | WO2006024488A2 Medical stent provided with inhibitors of atp synthesis |
| 03/09/2006 | WO2005122379A9 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 03/09/2006 | WO2005110477A3 Combination therapies for cancer and proliferative angiopathies |
| 03/09/2006 | WO2005092442A3 Method and compositions for treatment of chronic neuropathic pain |
| 03/09/2006 | WO2005086971A3 Anti-metastatic ability of mibefradil and gadolinium |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052456 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 03/09/2006 | US20060052455 Composition for preventing treating the xepression of clinical symptom in disease caused by mitochondrial dysfunction |
| 03/09/2006 | US20060052441 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods |
| 03/09/2006 | US20060052437 Combination of an hmg-coa reductase inhibitor and a nitrate ester |
| 03/09/2006 | US20060052435 Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052405 Hair loss prevention |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052367 Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker |
| 03/09/2006 | US20060052364 Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors |
| 03/09/2006 | US20060052351 Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress |
| 03/09/2006 | US20060052341 Control of a biological function |
| 03/09/2006 | US20060052333 Method of treating arrhythmias |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052319 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 03/09/2006 | US20060052317 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 03/09/2006 | US20060052314 Pharmaceutical combination |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060052298 Use of stable glutamine derivatives to improve drug absorption |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051754 Transporter selectively transporting sulfate conjugate and its gene |
| 03/09/2006 | US20060051438 Herbal medicaments for the treatment of neurocerebrovascular disorders |
| 03/09/2006 | US20060051429 Pharmaceutical compositions and methods for managing skin conditions |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051295 Estrogen receptor interaction with a transcription factor |
| 03/09/2006 | CA2620919A1 Perorally administrable antimicrobial composition |
| 03/08/2006 | EP1632499A2 Gene sequences amplified in tumours and their diagnostic uses |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632471A1 Racemic and optically pure metabolites of Sibutramine, their preparation, compositions comprising them and their use as Dopamine reuptake inhibitors |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632249A1 Osteogenesis-promotion enhancer and method of screening the same |
| 03/08/2006 | EP1632246A2 Medicament for local use |
| 03/08/2006 | EP1632239A1 Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use |
| 03/08/2006 | EP1632238A1 Encapsulated cells adapted for implantation into the aqueous and vitreous humor of the eye |
| 03/08/2006 | EP1632226A1 Anti-inflammatory analgesic adhesive patch |
| 03/08/2006 | EP1631556A1 Pharmaceutical composition comprising valsartan |
| 03/08/2006 | EP1631304A1 Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care |
| 03/08/2006 | EP1631303A2 Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631294A1 A method of treating an anxiety disorder |
| 03/08/2006 | EP1631293A2 Compounds, formulations, and methods for treating or preventing rosacea |
| 03/08/2006 | EP1631283A1 Antiarthritic combinations |